Patents by Inventor Lauren Schwimmer

Lauren Schwimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTISPECIFIC BINDING COMPOUNDS THAT BIND TO PD-L1
    Publication number: 20240084014
    Abstract: Multispecific binding compounds that bind to PD-L1 are disclosed, along with methods of making such binding compounds, compositions, including pharmaceutical compositions, comprising such binding compounds, and their use to treat disorders that are characterized by the expression of PD-L1.
    Type: Application
    Filed: October 15, 2021
    Publication date: March 14, 2024
    Inventors: Shenda Gu, Shihao Chen, Lauren Schwimmer
  • MAdCAM targeted immunotolerance
    Patent number: 11739146
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: August 29, 2023
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards, Erik Sampson, Jacob Glanville, David Maurer, Sarah Ives, Christina Pettus, Lauren Schwimmer
  • TARGETED IMMUNOTOLERANCE WITH A PD-1 AGONIST
    Publication number: 20210206856
    Abstract: Methods and polypeptides for conferring site-specific or local immune privilege.
    Type: Application
    Filed: August 19, 2020
    Publication date: July 8, 2021
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Salvatore Alioto, Lindsay J. Edwards, Jacob Glanville, David Maurer, Sarah Ives, Sawsan Youssef, Devanshi Shanghavi, Lauren Schwimmer
  • ANTIBODIES THAT BIND INTERLEUKIN-2 AND USES THEREOF
    Publication number: 20210188969
    Abstract: The present disclosure relates, in general, to human antibodies against human interleukin 2 (IL-2) and methods of use of such antibodies for modulating IL-2 activity and use in the treatment of conditions such as cancer, autoimmune disease, or infection.
    Type: Application
    Filed: December 4, 2020
    Publication date: June 24, 2021
    Inventors: Marina Roell, Mark Rubinstein, Hassan Issafras, Llewelyn Lao, Ou Li, Daniel H. Bedinger, Kristin Camfield Lind, Agnes Choppin Holmes, Toshihiko Takeuchi, Lauren Schwimmer, Hoa Giang, Amer M. Mirza, Kirk W. Johnson
  • MAdCAM TARGETED IMMUNOTOLERANCE
    Publication number: 20200392228
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.
    Type: Application
    Filed: May 20, 2020
    Publication date: December 17, 2020
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards, Erik Sampson, Jacob Glanville, David Maurer, Sarah Ives, Christina Pettus, Lauren Schwimmer
  • Antibodies that bind interleukin-2 and uses thereof
    Patent number: 10858428
    Abstract: The present disclosure relates, in general, to human antibodies against human interleukin 2 (IL-2) and methods of use of such antibodies for modulating IL-2 activity and use in the treatment of conditions such as cancer, autoimmune disease, or infection.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: December 8, 2020
    Assignees: XOMA (US) LLC, MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
    Inventors: Marina Roell, Mark Rubinstein, Hassan Issafras, Llewelyn Lao, Ou Li, Daniel H. Bedinger, Kristin Camfield Lind, Agnes Choppin Holmes, Toshihiko Takeuchi, Lauren Schwimmer, Hoa Giang, Amer M. Mirza, Kirk W. Johnson
  • Antibodies That Bind Interleukin-2 and Uses Thereof
    Publication number: 20180094053
    Abstract: The present disclosure relates, in general, to human antibodies against human interleukin 2 (IL-2) and methods of use of such antibodies for modulating IL-2 activity and use in the treatment of conditions such as cancer, autoimmune disease, or infection.
    Type: Application
    Filed: September 28, 2017
    Publication date: April 5, 2018
    Inventors: Marina Roell, Mark Rubinstein, Hassan Issafras, Llewelyn Lao, Ou Li, Daniel H. Bedinger, Kristin Camfield Lind, Agnes Choppin Holmes, Toshihiko Takeuchi, Lauren Schwimmer, Hoa Giang, Amer M. Mirza, Kirk W. Johnson
  • Engineering Enzymes Through Genetic Selection
    Publication number: 20070298414
    Abstract: Methods and compositions for selecting transformed cells are provided. An exemplary method combines chemical complementation with genetic selection to identify desirable transformed cells.
    Type: Application
    Filed: November 17, 2004
    Publication date: December 27, 2007
    Inventors: Donald Doyle, Lauren Schwimmer, Bahareh Azizi